Financials Evrofarma SA

Equities

EVROF

GRS385113006

Food Processing

Market Closed - Athens S.E. 15:10:10 24/05/2024 BST 5-day change 1st Jan Change
1.64 EUR +1.55% Intraday chart for Evrofarma SA -2.96% +36.67%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 4.512 8.819 15.93 13.04 12.44 9.735
Enterprise Value (EV) 1 24.35 26.72 34.41 31.15 33.5 29.68
P/E ratio 8.42 x 9.01 x 101 x 12.1 x -35 x 6.86 x
Yield - - - - - -
Capitalization / Revenue 0.15 x 0.27 x 0.48 x 0.38 x 0.34 x 0.21 x
EV / Revenue 0.79 x 0.82 x 1.03 x 0.92 x 0.91 x 0.65 x
EV / EBITDA 7.36 x 8.15 x 9.65 x 11 x 20.5 x 7.04 x
EV / FCF 16.5 x 12.3 x 20.6 x 409 x -13.8 x 42.8 x
FCF Yield 6.06% 8.15% 4.86% 0.24% -7.27% 2.34%
Price to Book 0.42 x 0.76 x 1.34 x 1.01 x 0.99 x 0.69 x
Nbr of stocks (in thousands) 13,673 13,673 13,673 13,673 13,673 13,673
Reference price 2 0.3300 0.6450 1.165 0.9540 0.9100 0.7120
Announcement Date 30/04/18 24/04/19 17/06/20 29/04/21 29/04/22 18/04/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 30.64 32.54 33.48 33.91 36.7 45.38
EBITDA 1 3.306 3.279 3.565 2.839 1.634 4.218
EBIT 1 1.77 1.873 2.186 1.497 0.231 2.725
Operating Margin 5.78% 5.76% 6.53% 4.41% 0.63% 6%
Earnings before Tax (EBT) 1 1.111 1.261 0.326 1.195 -0.26 1.522
Net income 1 0.536 0.979 0.157 1.08 -0.355 1.419
Net margin 1.75% 3.01% 0.47% 3.18% -0.97% 3.13%
EPS 2 0.0392 0.0716 0.0115 0.0790 -0.0260 0.1038
Free Cash Flow 1 1.474 2.177 1.671 0.0762 -2.435 0.6935
FCF margin 4.81% 6.69% 4.99% 0.22% -6.64% 1.53%
FCF Conversion (EBITDA) 44.6% 66.39% 46.87% 2.69% - 16.44%
FCF Conversion (Net income) 275.07% 222.37% 1,064.17% 7.06% - 48.87%
Dividend per Share - - - - - -
Announcement Date 30/04/18 24/04/19 17/06/20 29/04/21 29/04/22 18/04/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 19.8 17.9 18.5 18.1 21.1 19.9
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 6 x 5.459 x 5.184 x 6.378 x 12.89 x 4.728 x
Free Cash Flow 1 1.47 2.18 1.67 0.08 -2.44 0.69
ROE (net income / shareholders' equity) 5.12% 8.75% 1.33% 8.7% -2.78% 10.7%
ROA (Net income/ Total Assets) 2.49% 2.62% 3.2% 2.14% 0.31% 3.59%
Assets 1 21.52 37.35 4.909 50.55 -114.2 39.55
Book Value Per Share 2 0.7800 0.8500 0.8700 0.9500 0.9200 1.030
Cash Flow per Share 2 0.0600 0.0400 0.0100 0.2300 0.0200 0.1100
Capex 1 0.81 0.82 - 0.9 3.35 2.05
Capex / Sales 2.64% 2.53% - 2.67% 9.12% 4.53%
Announcement Date 30/04/18 24/04/19 17/06/20 29/04/21 29/04/22 18/04/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. EVROF Stock
  4. Financials Evrofarma SA